Difference between revisions of "Part:BBa K929100:Design"

 
(→‎References)
 
Line 1: Line 1:
−
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K929100 short</partinfo>
 
<partinfo>BBa_K929100 short</partinfo>
Line 16: Line 15:
  
 
===References===
 
===References===
 +
[1]  Bruell D, Bruns CJ, Yezhelyev M, Huhn M, Müller J, Ischenko I, Fischer R, Finnern R, Jauch KW, Barth S ( 2005) Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice. International Journal of Molecular Medicine; 15, 305-13

Latest revision as of 09:10, 24 September 2012

Anti-EGFR scFv425


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 538
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

PstI mutations originally occurring in the initial scFv425 sequence were eliminated by mutagenesis PCR.


Source

Plasmid pKMEF425bla

References

[1] Bruell D, Bruns CJ, Yezhelyev M, Huhn M, Müller J, Ischenko I, Fischer R, Finnern R, Jauch KW, Barth S ( 2005) Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice. International Journal of Molecular Medicine; 15, 305-13